- Home
- CGEM vs ANGO Comparison
CGEM vs ANGO Comparison
Compare CGEM & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- ANGO
- Stock Information
- Founded
- CGEM 2016
- ANGO 1988
- Country
- CGEM United States
- ANGO United States
- Employees
- CGEM N/A
- ANGO N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- ANGO Medical/Dental Instruments
- Sector
- CGEM Health Care
- ANGO Health Care
- Exchange
- CGEM Nasdaq
- ANGO Nasdaq
- Market Cap
- CGEM 482.7M
- ANGO 400.8M
- IPO Year
- CGEM 2021
- ANGO 2004
- Fundamental
- Price
- CGEM $6.45
- ANGO $10.82
- Analyst Decision
- CGEM Strong Buy
- ANGO Strong Buy
- Analyst Count
- CGEM 8
- ANGO 3
- Target Price
- CGEM $27.25
- ANGO $19.00
- AVG Volume (30 Days)
- CGEM 525.8K
- ANGO 360.4K
- Earning Date
- CGEM 11-06-2025
- ANGO 10-02-2025
- Dividend Yield
- CGEM N/A
- ANGO N/A
- EPS Growth
- CGEM N/A
- ANGO N/A
- EPS
- CGEM N/A
- ANGO N/A
- Revenue
- CGEM N/A
- ANGO $292,498,000.00
- Revenue This Year
- CGEM N/A
- ANGO $7.13
- Revenue Next Year
- CGEM N/A
- ANGO $6.28
- P/E Ratio
- CGEM N/A
- ANGO N/A
- Revenue Growth
- CGEM N/A
- ANGO N/A
- 52 Week Low
- CGEM $6.44
- ANGO $5.83
- 52 Week High
- CGEM $18.62
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- CGEM 36.01
- ANGO 72.55
- Support Level
- CGEM $6.44
- ANGO $10.66
- Resistance Level
- CGEM $7.82
- ANGO $11.04
- Average True Range (ATR)
- CGEM 0.43
- ANGO 0.30
- MACD
- CGEM -0.11
- ANGO 0.08
- Stochastic Oscillator
- CGEM 4.55
- ANGO 83.53
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.